Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

ARTICLES

176 POSTS

Exclusive articles:

Charming Medical Prices U.S. IPO at $4, Underscoring Investor Caution Toward Small-Cap China Deals

Charming Medical Holdings Ltd., a Hong Kong-based wellness and aesthetic services provider, has priced its U.S. initial public offering (IPO) at $4 per share,...

PPHC Sets Terms for $60 Million IPO as Government Relations Services Gain Momentum

Public Policy Holding Company (PPHC), a U.S.-based provider of government relations and public affairs services, has set the terms for its upcoming $60 million...

Calisa Acquisition Corp. Prices $60 Million SPAC IPO, Eyes High-Growth Businesses in Asia

  Calisa Acquisition Corp., a newly formed special purpose acquisition company (SPAC), has priced its $60 million initial public offering, signaling renewed investor interest in...

Solar EV Developer Aptera Motors Set for Nasdaq Direct Listing

Aptera Motors, the California-based startup pioneering solar electric vehicles, is set to make its public market debut through a direct listing on the Nasdaq...

Rubicon Research Ltd. IPO: Indian Pharma Innovator Targets Global Growth

Rubicon Research Ltd., a Mumbai-based pharmaceutical formulation company, is gearing up for its initial public offering (IPO), aiming to raise approximately ₹600 crore to...

Breaking

SKN | Geothermal Developer Fervo Energy Files for Estimated $250 Million IPO

Fervo Energy, a next-generation geothermal energy developer, has filed...

SKN | Mobia Medical Files for $100M IPO as Neurostimulation Therapy Targets $30B Stroke Market

FDA-Approved Device Positions Company in High-Value Neurorehabilitation Segment Mobia Medical...

SKN | Amatuhi Holdings Raises IPO Range as Investor Demand Lifts Expected Proceeds by 60%

Revised Pricing Signals Stronger Market Interest Ahead of Nasdaq...

SKN | Alamar Biosciences Prices Upsized IPO at $17, the High End of the Range

Alamar Biosciences has priced its upsized initial public offering...
spot_imgspot_img